Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.6000
-0.0585 (-8.88%)
May 15, 2026, 4:00 PM EDT - Market closed
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.95 million as of May 15, 2026. Its market cap has increased by 88.04% in one year.
Market Cap
3.95M
Enterprise Value
-14.21M
1-Year Change
88.04%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.95M, a decrease of -97.29%. That is a compound annual growth rate of -25.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 3.90M | -4.88% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiomX | 4.17M |
| CNS Pharmaceuticals | 4.02M |
| Akari Therapeutics, | 3.95M |
| Alzamend Neuro | 3.88M |
| VivoSim Labs | 3.73M |
| Soligenix | 3.71M |
| 60 Degrees Pharmaceuticals | 3.67M |
| Revelation Biosciences | 3.64M |